Lynn Rudman
Gynecology · Santa Barbara, CANPI 1710971353
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Amgen at 35.6% of the total. Reporting peaked in 2019 at $957 and has fallen 52.8% since, to $452 in 2025.
Across 292 payments — averaging $12.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$458
- Therapeuticsmd, Inc.$365
- Ascend Therapeutics US, LLC$293
- Astellas Pharma US Inc$249
- AMAG Pharmaceuticals, Inc.$234
- plus $735 from 11 others
What the payments were for
- Food & beverage$3,29991%
- Education$2457%
- Gifts$782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 32 | $1,289 |
| AbbVie | 43 | $458 |
| Therapeuticsmd, Inc. | 11 | $365 |
| Ascend Therapeutics US, LLC | 149 | $293 |
| Astellas Pharma US Inc | 12 | $249 |
| AMAG Pharmaceuticals, Inc. | 12 | $234 |
| Hologic Sales And Service, LLC | 2 | $158 |
| Millicent US Inc | 8 | $146 |
| Pfizer | 5 | $108 |
| Evofem Biosciences, Inc. | 4 | $70 |
| Mayne Pharma Commercial LLC | 4 | $65 |
| Myovant Sciences Inc. | 3 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| Shield Therapeutics Inc | 2 | $31 |
| Cook Medical LLC | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,623 in reported general payments places this provider in the 75th percentile of 247 gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EstringEstradiol | 21 | $11,114 |
| Estradiol | 77 | $10,945 |
| MyrbetriqMirabegron | 12 | $7,070 |
| YuvafemEstradiol | 33 | $6,390 |
| Estradiol (Twice Weekly)Estradiol | 28 | $3,256 |
| ImvexxyEstradiol | 13 | $2,735 |
| DottiEstradiol | 27 | $2,301 |
| ProgesteroneProgesterone, Micronized | 33 | $965 |
| ValacyclovirValacyclovir Hcl | 30 | $914 |
| Acyclovir | 13 | $158 |
| Alendronate Sodium | 22 | $87 |
| Fluconazole | 15 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEstring | $108 | $11,11421 claims |
| Astellas Pharma US IncMyrbetriq | $249 | $7,07012 claims |
| Therapeuticsmd, Inc.Imvexxy | $365 | $2,73513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 247 gynecology providers in California.
Other gynecology in Santa Barbara
- Bruce LeeMonterey$2.8M
- Barbara Levyla Jolla$719K
- Samar NahasRiverside$132K
- Aarathi CholkeriEl Segundo$128K
- Kelly WrightLos Angeles$119K
- Naphthali AlinsodLaguna Beach$108K
- Albertine OmaniOakland$70K
- Matthew SiedhoffBeverly Hills$67K
- Justin DiedrichAgoura Hills$46K
- Thomas CunninghamMonterey$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.